Similar articles

• Vasomotor menopausal symptoms and risk of coronary heart disease: a life course perspective.

  Hardy R. Hardy R. Menopause. 2011 Feb;18(2):127-8. doi: 10.1097/gme.0b013e3182026c35. Menopause. 2011. PMID: 21135711 No abstract available.
• Estradiol gel 0.1% relieves vasomotor symptoms independent of age, ovarian status, or uterine status.

  Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB. Hedrick RE, et al. Menopause. 2010 Nov-Dec;17(6):1167-73. doi: 10.1097/gme.0b013e3181e04b75. Menopause. 2010. PMID: 20720511
• Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.

  Alexander JL, Burger H, Dennerstein L, Woods NF, Davis SR, Kotz K, Van Winkle J, Richardson G, Ratka A, Kessel B. Alexander JL, et al. Expert Rev Neurother. 2007 Nov;7(11 Suppl):S115-37. doi: 10.1586/14737175.7.11s.S115. Expert Rev Neurother. 2007. PMID: 18039061 Review.
• Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.

  Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Reed SD, et al. Menopause. 2008 Jan-Feb;15(1):51-8. Menopause. 2008. PMID: 18257142 Clinical Trial.
• Hormonal and nonhormonal treatment of vasomotor symptoms.

  Krause MS, Nakajima ST. Krause MS, et al. Obstet Gynecol Clin North Am. 2015 Mar;42(1):163-79. doi: 10.1016/j.ogc.2014.09.008. Epub 2014 Dec 2. Obstet Gynecol Clin North Am. 2015. PMID: 25681847 Review.